[HTML][HTML] Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis
Abstract Background/Purpose Orthokeratology (Ortho-K), atropine eye drops and combined
atropine with Ortho-K are proven to be effective ways to prevent myopic progression in many …
atropine with Ortho-K are proven to be effective ways to prevent myopic progression in many …
Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report
Purpose (1) To compare the efficacy of continued and stop** treatment for 0.05%, 0.025%,
and 0.01% atropine during the third year.(2) To evaluate the efficacy of continued treatment …
and 0.01% atropine during the third year.(2) To evaluate the efficacy of continued treatment …
A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS …
Purpose To evaluate the efficacy of a myopia control spectacle lens (DIMS) at slowing the
progression of myopia in a population of European children in comparison with 0.01 …
progression of myopia in a population of European children in comparison with 0.01 …
Topical review: studies on management of myopia progression from 2019 to 2021
METHODS In this nonsystematic review, we searched PubMed and the Cochrane
databases for English-language studies published from 2019 to September 2021, for …
databases for English-language studies published from 2019 to September 2021, for …
Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
I Pérez-Flores, B Macías-Murelaga, J Barrio-Barrio - Scientific reports, 2023 - nature.com
To evaluate the age-related efficacy and safety of atropine 0.01% eye drops over 2 years for
myopia control in a multicentric pediatric Spanish cohort. A non-controlled, interventional …
myopia control in a multicentric pediatric Spanish cohort. A non-controlled, interventional …
Myopia control with low-dose atropine in European children: six-month results from a randomized, double-masked, placebo-controlled, Multicenter study
A Hvid-Hansen, N Jacobsen, F Møller, T Bek… - Journal of Personalized …, 2023 - mdpi.com
The effect and safety of low-dose atropine in myopia control have not been studied in
randomized, placebo-controlled trials outside Asia. We investigated the efficacy and safety …
randomized, placebo-controlled trials outside Asia. We investigated the efficacy and safety …
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial …
NC Hansen, A Hvid-Hansen, F Møller, T Bek… - BMC …, 2023 - Springer
Background To investigate the efficacy and safety of 0.1% and 0.01% low-dose atropine eye
drops in reducing myopia progression in Danish children. Methods Investigator-initiated …
drops in reducing myopia progression in Danish children. Methods Investigator-initiated …
Is 0.01% atropine an effective and safe treatment for myopic children? A systemic review and meta-analysis
Several conflicting results regarding the efficacy of 0.01% atropine in slowing axial
elongation remain in doubt. To solve this issue and evaluate the safety of 0.01% atropine …
elongation remain in doubt. To solve this issue and evaluate the safety of 0.01% atropine …
Efficacy and Safety of Low-Dose Atropine on Myopia Prevention in Premyopic Children: Systematic Review and Meta-Analysis
SH Lee, BY Tseng, JH Wang, CJ Chiu - Journal of Clinical Medicine, 2024 - mdpi.com
Background: Early-onset myopia increases the risk of irreversible high myopia. Methods:
This study systematically evaluated the efficacy and safety of low-dose atropine for myopia …
This study systematically evaluated the efficacy and safety of low-dose atropine for myopia …
Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms
Introduction Myopia is a major cause of degenerative eye disease and increases the risk of
secondary visual impairment. Mitigating its progression therefore has great potential of …
secondary visual impairment. Mitigating its progression therefore has great potential of …